Поиск
Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
AGENDA
2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics
Topic 1: Large Language Models in...
Revolutionizing Addiction Medicine: The Role of Artificial Intelligence
Introduction
Addiction medicine is becoming more of an issue as addiction-related problems continue to plague people all over the globe, resulting in serious health consequences. Addiction has become increasingly prevalent in recent years...
Exploring the Potential and Challenges of Digital and AI-Driven Psychotherapy for ADHD, OCD, Schizophrenia, and Substance Use Disorders: A Comprehensive Narrative Review
Purpose of the Review:
Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...
Digital interventions targeting excessive substance use and substance use disorders: a comprehensive and systematic scoping review and bibliometric analysis
Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...
A systematic review of chatbot-assisted interventions for substance use
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs.
Methods: Foll...
Clinical implementation of AI-based screening for risk for opioid use disorder in hospitalized adults
The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...
إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة
يهدف دليل إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة إلى مساعدة القادة والمديرين على ترجمة المعرفة الحالية وأفضل الممارسات الأخلاقية والفعّالة في مجال العلاج إلى تطبيق عملي. كما يساعد المديرين على...
Child and youth mental health in the WHO European Region: Status and actions to strengthen quality of care
For the first time WHO Regional Office for Europe brings together all of data available at the Regional level on child and youth mental health. One in seven children and adolescents aged 0–19 years old lives with a mental health condition...
Day 2, 11:00 - 12:00, Plenary 8: Quality Assurance for Drug Treatment Services
Panel Presented at Indonesia 2025 on the 18th of September 2025
Moderator: Kristiana Siste
Presentations:
Narendra Narotama: Quality Matters: Transforming the Future of Drug Use Disorder Treatment
Annete Dale-Perera: Supporting...
Day 1, 16:00 - 17:30, Plenary 4: Reducing Drug Related Crimes in the Community
Panel Presented at Indonesia 2025 on the 17th of September 2025
Moderator: Imelda Indriyani
Presentations:
Mirza Hapsari Massarapa: Reducing Drug-Related Crime: A Comprehensive Approach from the Indonesian Directorate General of...
Day 1, 14:00 - 15:30, Plenary 3: Establishing Global-Regional Collaboration in Prevention, Treatment and Recovery Programs
Panel Presented at Indonesia 2025 on the 17th of September 2025
Moderator: Goodman Sibeko
Presentations:
Ma Veronica Felipe: International Consortium of Universities for Drug Demand Reduction
Joanna Travis-Roberts: Global Opportunities...
Mental Health Policy in the Management of Drug Abuse Disorders
Day 1, 10:30 - 12:00, Plenary 1: A Landscape of Addiction Problem – Comprehensive Approach and Treatment
Panel Presented at Indonesia 2025 on the 17th of September 2025
Moderator: Vivi Syarif
Presentations:
Erik Van der Veen: From Evidence to Action: Building Partnerships to Strengthen the Drug Demand Reduction Strategy
Bina Ampera Bukit:...
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of Interv...
The Digital Drug
I recently had the privilege of presenting at the Afri-Asia Drug Prevention & Treatment Summit 2025 in Nairobi, Kenya.
The paper, titled “"Screen Addiction vs Substance Addiction: A Neuroscience and Behavioral Science Analysis.,” explored...
Fentanyl in Cocaine: What New York Families Need to Know Right Now
Strengthening Leadership in Prevention: Sharing Insights from the Development of an Evidence-Based Workshop
Integrated Care for Syndemics: Bringing SUD, HIV & HCV Treatment Together
Alcohol increases your risk of premature death
Highlights how drinking alcohol increases the risk of dying before the age of 75 (also known as premature death). With simple visuals, shows how many people out of 1,000 could die early based on the number of standard drinks they consume...
Workplace Prevention in Practice Pt.4: Building Resilient and Healthy Work Environments
In this final episode, Associate Professors Goodman Sibeko and Nadine Harker shift the focus from individual-level responses to the organisational systems that shape wellbeing at work. The conversation looks at how workplaces can create...
Поделитесь знаниями: Члены ISSUP могут размещать информацию в разделе "Обмен знаниями" - зарегистрируйтесь или станьте членом организации